I understand that Goldman Sachs have pleaded with Conman Dan to allow them to do an IPO in May to raise $3 billion valuing SHITTYA at $120 billion. They especially like SHITTYA because they have no patents, no clinical data, are led by a convicted fraudster* & have run afoul of the US FDA**
** The US FDA threw out SHITTYA's IND application for their Phase 1 trial due to dubious figures & claims which is why they are trying to do a trial in Mexico unsanctioned by the FDA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.